VERORABVAX Trademark

Trademark Overview


On Wednesday, March 17, 2021, a trademark application was filed for VERORABVAX with the United States Patent and Trademark Office. The USPTO has given the VERORABVAX trademark a serial number of 90584798. The federal status of this trademark filing is REGISTERED as of Tuesday, February 28, 2023. This trademark is owned by Sanofi Pasteur. The VERORABVAX trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
verorabvax

General Information


Serial Number90584798
Word MarkVERORABVAX
Filing DateWednesday, March 17, 2021
Status700 - REGISTERED
Status DateTuesday, February 28, 2023
Registration Number6988438
Registration DateTuesday, February 28, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 13, 2022

Trademark Statements


Description of MarkThe mark consists of the stylized wording "VERORABVAX". "VERORAB" appears in teal and "VAX" in orange. A stylized arc appears above the wording beginning at and connected to the top of the right side of the first "V" and ending above the second "V". The left portion of the arc is in teal and the right portion is in orange. The stylized profile of an orange dog's head is attached to the right end of the arc and has a cutout of another dog's head within. All instances of the color white represent background or transparent area only and are not claimed as a feature of the mark.
Goods and ServicesVaccines for human use
Indication of Colors claimedThe color(s) teal and red is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSanofi Pasteur
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLyon 69007
FR

Party NameSanofi Pasteur
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLyon 69007
FR

Party NameSanofi Pasteur
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLyon 69007
FR

Trademark Events


Event DateEvent Description
Tuesday, February 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 28, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, December 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 30, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 30, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 30, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, May 24, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, May 24, 2022FINAL REFUSAL E-MAILED
Tuesday, May 24, 2022FINAL REFUSAL WRITTEN
Tuesday, April 19, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 19, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 19, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 20, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 20, 2021NON-FINAL ACTION E-MAILED
Wednesday, October 20, 2021NON-FINAL ACTION WRITTEN
Tuesday, October 19, 2021ASSIGNED TO EXAMINER
Friday, June 18, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, June 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 16, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, June 14, 2021ASSIGNED TO LIE
Tuesday, March 23, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Saturday, March 20, 2021NEW APPLICATION ENTERED

Related Keywords


verorabvax human vaccines